Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Cipla Health Introduces Nicotex Begin, a First-of-Its-Kind App for Smoking Cessation


News provided by

Cipla Health

15 May, 2025, 13:54 IST

Share this article

Share toX

Share this article

Share toX

5 times more effective, science-backed way to quit smoking

MUMBAI, India, May 15, 2025 /PRNewswire/ -- In an effort to help smokers in their journey to quit smoking Nicotex, the market leader in smoking cessation has launched Nicotex Begin, a smoking cessation program delivered via a mobile app. Coming from the house of Cipla Health Limited, this first-of-its-kind platform is not just an app, it's a comprehensive, science-backed approach to quitting smoking that promises to increase the chances of quitting smoking by 5 times.

Continue Reading
Cipla Health Introduces Nicotex Begin, a First-of-Its-Kind App for Smoking Cessation
Cipla Health Introduces Nicotex Begin, a First-of-Its-Kind App for Smoking Cessation

Nicotex Begin provides a 12-Week Personalised Smoking Cessation Program which is a step-by-step, guided journey to quitting smoking combining behavioural therapy with WHO-recommended Nicotine Replacement Therapy (NRT) protocols. With this combination therapy, Nicotex Begin offers a comprehensive 360-degree support ecosystem that addresses the physical and psychological challenges of smoking cessation.

Commenting on the launch, Mr. Shivam Puri, MD & CEO, Cipla Health Limited, said, "At Cipla Health, we understand that quitting smoking is more than just a decision, it's a life-changing journey. That's why we've poured our energy into creating Nicotex Begin, a truly innovative solution designed to make the process easier, more structured, accessible, and far more effective. With our research showing a 5X higher chance of success, this is not just another product; it's a game-changer. It's a reflection of our relentless drive to not only improve wellness but also empower individuals to take control of their health and transform their lives. We're here to support people on this journey, every step of the way"

With its intuitive design and user interface, it ensures an engaging and stress-free experience for the users. Some other key features include Nicotine Replacement Therapy (NRT) integration with gums, patches, and lozenges to ease nicotine cravings, along with expert-led weekly counselling sessions, with additional sessions available as needed. Users can choose from two package options priced at ₹4,000 and ₹6,000 with the first session offered free.

The app also provides reading materials and videos to keep users motivated, tracks quitting progress through interactive prompts and data insights, and includes a daily health diary for users to log progress and keep counsellors informed. It proactively addresses potential relapse triggers, allowing experts to guide users back to week one or recommend medical consultation when necessary, ensuring a comprehensive and supportive quit-smoking journey.

It is available for download on Android and soon to be launched on iOS devices.

About Cipla Health Limited:

Cipla Health Limited, the fast-moving wellness goods (FMWG) arm of Cipla, was incorporated in 2015 with a vision to spearhead the wellness wave in India. Cipla Health has delivered rapid growth and today plays across a diverse portfolio of 20 brands with most key brands being No. 1 or No. 2 in their respective categories. The portfolio includes products in Pain Care (Omnigel), Smoking Cessation (Nicotex), Oral Rehydration Solutions (Prolyte), Medicated Ointments (Cipladine), Cough & Cold (Cofsils and Naselin), Multi Vitamins (Maxirich), Weight Gain (Endura Mass) and Personal Care (Rivela Dermascience, Cetafresh, Tugain Essentials).

Photo: https://mma.prnewswire.com/media/2688253/Nicotex_Begin.jpg

Modal title

Also from this source

Cipla Health takes a humorous spin on real life stories with Astaberry's campaign 'Get the Rich Look'

Cipla Health takes a humorous spin on real life stories with Astaberry's campaign 'Get the Rich Look'

Cipla Health, a leading player in the wellness category, announced the launch of Astaberry, its beauty and personal care brand's latest campaign -...

Cipla Health reinforces importance of Self-Care This Season Through Its Range of Wellness Products

Cipla Health reinforces importance of Self-Care This Season Through Its Range of Wellness Products

Common flu, seasonal throat infections, and fevers are on the rise in India, making it imperative to practice every day self-care and community...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Fitness/Wellness

Fitness/Wellness

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.